Fig. 2: Progression-free survival (PFS) and overall survival (OS) according to the combination of interleukin (IL)-8 and the lymphocyte-to-monocyte ratio (LMR). | British Journal of Cancer

Fig. 2: Progression-free survival (PFS) and overall survival (OS) according to the combination of interleukin (IL)-8 and the lymphocyte-to-monocyte ratio (LMR).

From: The relationships between systemic cytokine profiles and inflammatory markers in colorectal cancer and the prognostic significance of these parameters

Fig. 2

a PFS (P < 0.001; low-risk group [low IL-8 and high LMR] vs intermediate-risk group [low IL-8 with low LMR or high IL-8 with high LMR], P < 0.001; low- vs high-risk group [high IL-8 and low LMR], P < 0.001; intermediate- vs high-risk group, P = 0.066). b OS (P < 0.001; low- vs intermediate-risk group, P = 0.008; low- vs high-risk group, P < 0.001; intermediate- vs high-risk group, P = 0.002).

Back to article page